Open the map

MedtronicMDT

Medtech & devices · NYSE · USA

$87.75
Up 2.6% todayClose

Down 11.0% this year but +8.4% since June 26, behind the life science sector at +10.7%. Medtronic supplies 1 mapped company.

Market cap
$112B
This year
−11.0%
1 year
−13.0%
P/E
21.3
P/S
3.0
P/B
2.2

Price vs the life science sector

since Jun 26MDTLife science sector, equal weight
Medtronic (MDT) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. MDT: +8.4% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+5%+10%+15%Jun 26AugSepOct 8MDT +8.4%Sector +10.7% Medtronic (MDT) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. MDT: +8.4% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+5%+10%+15%Jun 26AugSepOct 8MDT+8.4%Sector+10.7%

Supply chain

1 customer
SUPPLIERS →→ CUSTOMERSNone mappedCardinal Health (CAH)CAHCardinal Health+2.9%MDTMedtronic

Customers 1

Open the full chain →

About Medtronic

Cardiac rhythm and cardiology devices anchor a catalogue that also runs through surgical equipment, neurology and diabetes treatment.

Theme exposure

MedtechCardiologyDiabetes exposureDiabetes

Products

  • Cardiac rhythm & cardiology
  • Surgery
  • Diabetes & neurology

Competitors

Risks

  • Mature markets
  • Currency exposure

Same segment: Medtech & devices

Medical equipment and devices, from surgery and cardiology to robotics. Segment 7 of 8 in the Medicine, pharma & life science value chain.

Intuitive SurgicalISRG+0.2%StrykerSYK+0.6%Boston ScientificBSX+1.1%Becton DickinsonBDX+1.4%Edwards LifesciencesEW−1.8%ResMedRMD+0.3%GE HealthCareGEHC−0.7%Zimmer BiometZBH+0.4%

Compare MDT

Side by side with the largest companies in the same segment.

MDT vs ISRGMDT vs SYKMDT vs BSXMDT vs BDXMDT vs EWMDT vs RMD

See where Medtronic sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →